Skip to main content
. 2022 Sep 28;17(1):193–203. doi: 10.1007/s12105-022-01487-w

Table 3.

Incisional Biopsy Diagnoses

Diagnostic challenge
Single definitive diagnosis
Favored diagnosis
SGT, undetermined
191 (77%)
38 (15%)
19 (8%)

Benign

Malignant

Undetermined

143 (58%)

91 (37%)

14 (6%)

Pathology diagnosis

Pleomorphic adenoma/myoepithelioma

Mucoepidermoid carcinoma

Polymorphous adenocarcinoma

Cystadenoma

Canalicular adenoma

Adenoid cystic carcinoma

Sialadenoma papilliferum

Ductal papilloma

Acinic cell carcinoma

Clear cell carcinoma

Adenocarcinoma, NOS

Basal cell adenoma

Secretory carcinoma

Oncocytoma

Epithelial-myoepithelial carcinoma

Myoepithelial carcinoma

Intraductal carcinoma

Carcinosarcoma

SGT, undetermined

99 (39.9%)

42 (16.9%)

20 (8.1%)

16 (6.5%)

16 (6.5%)

9 (3.6%)

6 (2.4%)

3 (1.2%)

3 (1.2%)

3 (1.2%)

3 (1.2%)

2 (1.2%)

2 (0.8%)

1 (0.4%)

1 (0.4%)

1 (0.4%)

1 (0.4%)

1 (0.4%)

19 (7.7%)

SGT: salivary gland tumor